糖尿病治療機器市場：用途、製品、流通別-2025-2030年の世界予測

糖尿病治療機器市場は、2023年に26億2,000万米ドルと評価され、2024年には31億米ドルに達すると予測され、CAGR 18.58%で成長し、2030年には86億4,000万米ドルに達すると予測されています。

糖尿病治療機器市場には、グルコースモニター、インスリン送達デバイス、糖尿病管理ソフトウェアなど、さまざまな製品が含まれ、これらはすべて、個人が糖尿病の状態を効果的に管理できるようにすることを目的としています。これらの機器の必要性は、ライフスタイルの変化や肥満率の増加によって、世界中で糖尿病人口が増加していることに起因しています。アプリケーションは、血糖値検査や持続グルコースモニタリング（CGM）からインスリン投与まで多岐にわたり、病院、診療所、在宅医療の現場で活用されています。主な成長要因としては、CGMシステムの技術的進歩、非侵襲的およびウェアラブルデバイスの採用増加、糖尿病管理を促進する政府の取り組みなどが挙げられます。さらに、糖尿病に対する認識と教育の高まりが市場のさらなる拡大につながります。個別化医療と予測分析を最適化できる糖尿病治療機器における人工知能と機械学習の統合は、1つの大きなビジネスチャンスです。企業は、ユーザーフレンドリーでコスト効率の高いソリューションを革新するために研究開発に投資すべきであり、特にヘルスケア・インフラが改善しつつある新興市場をターゲットとすべきです。しかし、先進デバイスの高コスト、厳しい規制当局の承認、データプライバシーに関する懸念などの制約が、市場成長の課題となっています。さらに、保険償還のシナリオは複雑で、地域によって一貫性がない場合があり、採用率に影響を与えています。また、急速に発展している分野としてハイブリッド・クローズドループ・システムがあり、これは将来のインスリン管理における重要な技術革新となります。全体として、糖尿病治療機器市場はダイナミックであり、技術強化、コスト削減戦略、過疎地域での拡大を通じてかなりの成長機会があります。テクノロジー企業とヘルスケアプロバイダーのコラボレーションは、イノベーションのパイプラインをさらに充実させ、障壁に効果的に対処することができます。患者のニーズと規制状況を理解し、強固なデータ管理フレームワークの構築に注力することが、長期的な市場競争力と成長を維持する上で重要になります。

市場力学：急速に進化する糖尿病治療機器市場の主要市場インサイトを公開

糖尿病治療機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 糖尿病人口の増加と糖尿病治療に対する意識の高まり
  • グルコースレベルモニタリングなどの新技術に対するニーズの高まり
  • 糖尿病治療に対する政府の支援策
• 市場抑制要因
  • 高度医療機器に関連する高コスト
• 市場機会
  • セルフケアや在宅ケアの動向の高まり
  • 先端技術の統合による機能性の向上
• 市場の課題
  • 未発達地域における認知度・普及度の不足

ポーターの5つの力：糖尿病治療機器市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、糖尿病治療機器市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：糖尿病治療機器市場における外部からの影響の把握

外部マクロ環境要因は、糖尿病治療機器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析糖尿病治療機器市場における競合情勢の把握

糖尿病治療機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス糖尿病治療機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、糖尿病治療機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨糖尿病治療機器市場における成功への道筋を描く

糖尿病治療機器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 糖尿病患者数の増加と糖尿病治療に対する意識の高まり
    • 血糖値モニタリングなどの新技術へのニーズの高まり
    • 糖尿病ケアに対する政府の支援策
  • 抑制要因
    • 高度な医療機器に関連する高コスト
  • 機会
    • セルフケアや在宅ケアの増加傾向
    • 先進技術の統合による機能性の向上
  • 課題
    • 未開発地域における認知度と浸透度の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 糖尿病治療機器市場用途別

• ポイントオブケア
• セルフテスト

第7章 糖尿病治療機器市場：製品別

• 血糖値モニタリング装置
  • 持続血糖モニター
  • ランセット
  • 自己血糖測定器
  • 検査ストリップ
• インスリン投与装置
  • インスリンジェットインジェクター
  • インスリンペン
  • インスリンポンプ
  • インスリン注射器

第8章 糖尿病治療機器市場配布元

• オフラインモード
• オンラインモード

第9章 南北アメリカの糖尿病治療機器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の糖尿病治療機器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの糖尿病治療機器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Acon Laboratories, Inc.
• AgaMatrix, Inc.
• Arkray, Inc.
• B. Braun SE
• Becton, Dickinson, and Company
• Bionime Corporation
• DexCom, Inc.
• Eli Lilly and Company
• F.Hoffmann-La Roche AG
• Johnson & Johnson Services, Inc.
• Medtronic PLC
• Nova Biomedical, Inc.
• Novo Nordisk A/S
• Sanofi S.A.

LIST OF FIGURES

• FIGURE 1. DIABETES CARE DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. DIABETES CARE DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DIABETES CARE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DIABETES CARE DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DIABETES CARE DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELFTEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE METERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN JET INJECTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE MODE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE MODE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 42. CANADA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. CANADA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 45. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 46. CANADA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 69. CHINA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 70. CHINA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. CHINA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 72. CHINA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 73. CHINA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 74. INDIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 75. INDIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. INDIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 77. INDIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 78. INDIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 160. ITALY DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 161. ITALY DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. ITALY DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 163. ITALY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 164. ITALY DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 180. POLAND DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 181. POLAND DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. POLAND DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 183. POLAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 184. POLAND DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 185. QATAR DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 186. QATAR DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. QATAR DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 188. QATAR DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 189. QATAR DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 235. DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 236. DIABETES CARE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Diabetes Care Devices Market was valued at USD 2.62 billion in 2023, expected to reach USD 3.10 billion in 2024, and is projected to grow at a CAGR of 18.58%, to USD 8.64 billion by 2030.

The diabetes care devices market encompasses a range of products including glucose monitors, insulin delivery devices, and diabetic management software, all aimed at helping individuals manage their diabetic condition effectively. The necessity of these devices stems from the growing diabetic population worldwide, driven by lifestyle changes and an increase in obesity rates. Applications span from blood glucose testing and continuous glucose monitoring (CGM) to insulin administration, which are utilized by hospitals, clinics, and home care settings. Key growth factors include technological advancements in CGM systems, rising adoption of non-invasive and wearable devices, and government initiatives promoting diabetes management. Moreover, increased awareness and education about diabetes lead to further market expansion. One significant opportunity lies in the integration of artificial intelligence and machine learning in diabetes care devices, which can optimize personalized medicine and predictive analytics. Companies should invest in R&D to innovate user-friendly and cost-effective solutions, particularly targeting emerging markets with improving healthcare infrastructure. However, limitations such as the high cost of advanced devices, stringent regulatory approvals, and data privacy concerns pose challenges for market growth. Additionally, the reimbursement scenario can be complex and inconsistent across regions, affecting adoption rates. Another fast-evolving area is the hybrid closed-loop systems, representing a significant innovation for future insulin management. Overall, the diabetes care devices market is dynamic, with considerable opportunity for growth through technological enhancement, cost-reduction strategies, and expansion in underpenetrated regions. Collaboration between technology firms and healthcare providers can further enrich the innovation pipeline and address barriers effectively. Understanding patient needs and regulatory landscapes, while focusing on building robust data management frameworks, will be critical in sustaining long-term market competitiveness and growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diabetes Care Devices Market

The Diabetes Care Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing diabetic population and rising awareness of diabetes treatment
  • Rising need for new technologies such as glucose level monitoring
  • Supportive government initiatives for diabetic care
• Market Restraints
  • High cost associated with advanced medical devices
• Market Opportunities
  • Increasing trend of self care or home care
  • Improved functionality with integration of advanced technologies
• Market Challenges
  • Lack of awareness and penetration in underdeveloped areas

Porter's Five Forces: A Strategic Tool for Navigating the Diabetes Care Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diabetes Care Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diabetes Care Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diabetes Care Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diabetes Care Devices Market

A detailed market share analysis in the Diabetes Care Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diabetes Care Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diabetes Care Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diabetes Care Devices Market

A strategic analysis of the Diabetes Care Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetes Care Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acon Laboratories, Inc., AgaMatrix, Inc., Arkray, Inc., B. Braun SE, Becton, Dickinson, and Company, Bionime Corporation, DexCom, Inc., Eli Lilly and Company, F.Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Medtronic PLC, Nova Biomedical, Inc., Novo Nordisk A/S, and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Diabetes Care Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Use, market is studied across Point-of-care and Selftest.
• Based on Product, market is studied across Blood Glucose Monitoring Devices and Insulin Delivery Devices. The Blood Glucose Monitoring Devices is further studied across Continuous Glucose Monitors, Lancets, Self-Monitoring Blood Glucose Meters, and Testing Strips. The Insulin Delivery Devices is further studied across Insulin Jet Injectors, Insulin Pens, Insulin Pumps, and Insulin Syringes.
• Based on Distribution, market is studied across Offline Mode and Online Mode.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing diabetic population and rising awareness of diabetes treatment
    • 5.1.1.2. Rising need for new technologies such as glucose level monitoring
    • 5.1.1.3. Supportive government initiatives for diabetic care
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with advanced medical devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing trend of self care or home care
    • 5.1.3.2. Improved functionality with integration of advanced technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of awareness and penetration in underdeveloped areas
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Diabetes Care Devices Market, by Use

• 6.1. Introduction
• 6.2. Point-of-care
• 6.3. Selftest

7. Diabetes Care Devices Market, by Product

• 7.1. Introduction
• 7.2. Blood Glucose Monitoring Devices
  • 7.2.1. Continuous Glucose Monitors
  • 7.2.2. Lancets
  • 7.2.3. Self-Monitoring Blood Glucose Meters
  • 7.2.4. Testing Strips
• 7.3. Insulin Delivery Devices
  • 7.3.1. Insulin Jet Injectors
  • 7.3.2. Insulin Pens
  • 7.3.3. Insulin Pumps
  • 7.3.4. Insulin Syringes

8. Diabetes Care Devices Market, by Distribution

• 8.1. Introduction
• 8.2. Offline Mode
• 8.3. Online Mode

9. Americas Diabetes Care Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Diabetes Care Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Diabetes Care Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Acon Laboratories, Inc.
• 3. AgaMatrix, Inc.
• 4. Arkray, Inc.
• 5. B. Braun SE
• 6. Becton, Dickinson, and Company
• 7. Bionime Corporation
• 8. DexCom, Inc.
• 9. Eli Lilly and Company
• 10. F.Hoffmann-La Roche AG
• 11. Johnson & Johnson Services, Inc.
• 12. Medtronic PLC
• 13. Nova Biomedical, Inc.
• 14. Novo Nordisk A/S
• 15. Sanofi S.A.